MyLongCovidAdvocacy
banner
covidimpact360.bsky.social
MyLongCovidAdvocacy
@covidimpact360.bsky.social
I aggregate, curate and post Infectious Disease Science, Research, Stories & News
Upheaval and firings at CDC raise fears about disease outbreak response
www.npr.org/sections/sho...

#MyLongCovidAdvocacy #NPR
Upheaval and firings at CDC raise fears about disease outbreak response
Staff and observers worry that the agency may not be prepared for emerging threats including bird flu and insect-borne diseases.
www.npr.org
February 26, 2025 at 3:50 PM
New bat virus HKU5-CoV-2 sparks pandemic fears - Is it the next COVID-19?
www.business-standard.com/health/new-b...

#MyLongCovidAdvocacy #HKU5-CoV-2
www.business-standard.com
February 24, 2025 at 6:45 PM
New Coronavirus HKU5-CoV-2 In Bats Can Infect Human Cells Just Like COVID-19
But researchers say the pathogen's potential to trigger a pandemic "should not be exaggerated".
www.iflscience.com/new-coronavi...

#MyLongCovidAdvocacy #ClinicEM
New Coronavirus HKU5-CoV-2 In Bats Can Infect Human Cells Just Like COVID-19
But researchers say the pathogen's potential to trigger a pandemic "should not be exaggerated".
www.iflscience.com
February 24, 2025 at 5:25 PM
When COVID Authoritarianism Met Border Authoritarianism
All 194 countries in the World Health Organization imposed COVID travel restrictions. The authors of When the World Closed Its Doors argue it was a failure.
reason.com/2025/02/18/w...

#CovidImpact360 #MyLongCovidAdvocacy
When COVID authoritarianism met border authoritarianism
All 194 countries in the World Health Organization imposed COVID travel restrictions. The authors of 'When the World Closed Its Doors' argue it was a failure.
reason.com
February 18, 2025 at 2:38 PM
European Commission Approves CSL and Arcturus Therapeutics’ KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine
www.stocktitan.net/news/ARCT/eu...

#CovidImpact360 #MyLongCovidAdvocacy
February 14, 2025 at 2:58 PM
Cutting-edge Recommendations Provide Treatment Path for Millions of Long COVID Patients
www.biospace.com/press-releas...

#CovidImpact360 #MyLongCovidAdvocacy
Cutting-edge Recommendations Provide Treatment Path for Millions of Long COVID Patients
www.biospace.com
February 12, 2025 at 3:10 PM
HealthBio™ Therapeutics Begins FDA-Approved Fast-Track Clinical Trial for Treatment of Long COVID with a Patented Combination of Maraviroc and Atorvastatin
www.businesswire.com/news/home/20...

#CovidImpact360 #MyLongCovidAdvocacy
HealthBio™ Therapeutics Begins FDA-Approved Fast-Track Clinical Trial for Treatment of Long COVID with a Patented Combination of Maraviroc and Atorvastatin
HealthBio (formerly IncellDx), an inflammatory disease diagnostic and therapeutic company, today announced it is pre-registering patients for its Phas
www.businesswire.com
February 12, 2025 at 3:01 PM
Single dose of broadly neutralizing antibody protects macaques from H5N1 influenza
NIH science lays groundwork for future studies in people.
www.nih.gov/news-events/...

#CovidImpact360 #MyLongCovidAdvocacy
Single dose of broadly neutralizing antibody protects macaques from H5N1 influenza
NIH science lays groundwork for future studies in people.
www.nih.gov
February 11, 2025 at 5:03 PM
Study suggests COVID-19 infection no longer grants long-lasting immunity
New research suggests that natural immunity after a COVID-19 infection has fallen sharply since Omicron became the dominant variant.
www.gavi.org/vaccineswork...

#CovidImpact360 #MyLongCovidAdvocacy
Study suggests COVID-19 infection no longer grants long-lasting immunity
New research suggests that natural immunity after a COVID-19 infection has fallen sharply since Omicron became the dominant variant.
www.gavi.org
February 11, 2025 at 4:44 PM
youtu.be/UAIC5RyDLuQ?...

Our 6th question out of 11 answered by Dr. McGroarty about SarsCoV2 and its disease Covid-19

#CovidImpact360 #MyLongCovidAdvocacy
COVID IMPACT 360° CONVERSATIONS | Q&A Session | Dr. Roy McGroarty | Question Six
YouTube video by Covid Impact 360° - Conversations
youtu.be
February 11, 2025 at 3:34 PM
Metabolomic profile of severe COVID-19 and a signature predictive of progression towards severe disease status: a prospective cohort study (METCOVID)
www.nature.com/articles/s41...

#CovidImpact360 #MyLongCovidAdvocacy
Metabolomic profile of severe COVID-19 and a signature predictive of progression towards severe disease status: a prospective cohort study (METCOVID) - Scientific Reports
Scientific Reports - Metabolomic profile of severe COVID-19 and a signature predictive of progression towards severe disease status: a prospective cohort study (METCOVID)
www.nature.com
February 10, 2025 at 3:29 PM